Form 4: Repligen Director Glenn P. Muir Exercises Stock Options

Repligen Corporation director Glenn P. Muir exercised stock options for 19,000 shares at a price of $36.29 per share on November 19, 2024.

Summary

• Glenn P. Muir, a director at Repligen Corporation, exercised stock options to acquire 19,000 shares of common stock.
• The transaction occurred on November 19, 2024, at an exercise price of $36.29 per share.
• Following the transaction, Mr. Muir directly owns 32,283 shares of Repligen common stock.
• The stock options were fully vested and exercisable on the transaction date.
• A power of attorney was granted to Marc Baumgartner, Jason Garland, and Jennifer Carmichael to handle SEC filings on behalf of Mr. Muir.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment, as it reports a routine transaction. The exercise of options by a director can be seen as a positive sign, but it's not a major event.

Positives

• The exercise of vested stock options by a director could be seen as a positive sign of confidence in the company's future.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders when they transact in their company's stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The exercise of stock options by directors is a common form of compensation and is not unusual in the biotechnology industry.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it increases the number of shares outstanding.

Key Dates

Keywords

Repligen, Stock Options, Form 4, Director, Insider Trading, Equity, Securities, RGEN